Related Experiment Videos
[Preventive use of antibiotics for internal medicine diseases]
1Departement für Innere Medizin, Kantonsspital, Universitätskliniken, Basel.
Abstract:
Prevention of infection by the interniste is less explored than perioperative prophylaxis. Basically, prophylaxis in internal medicine may be considered in the following situations: in case of chronic recurrent infections, in case of persisting infections, after contact with a dangerous microorganism, after contact with a potentially infectious vector, during bacteremia or in case of an anatomical defect. For some of these situations (malaria, tuberculosis, rheumatic fever) clear guidelines exist which, however, are rather based on the consensus of experts than on scientific data. For other diseases (e.g. chronic recurrent urinary tract infections) clinical studies are the basis for a rational proceeding. For a third group of situations (e.g. Lyme disease, chronic bronchitis, leak of cerebrospinal fluid, implant) neither guidance nor sufficient clinical data exist. In these cases the proceeding is individual. The basis for the decision is given by clinical observations, single studies, theoretical considerations or cost-benefit analyses.
Insights
Prophylaxis in internal medicine is less studied than surgical prevention. Guidelines exist for some infections like malaria and tuberculosis, but others lack clear data, requiring individualized treatment decisions.
Area of Science:
- Internal Medicine
- Infectious Disease Prevention
- Clinical Prophylaxis
Context:
- Perioperative prophylaxis is well-established, but infection prevention strategies within internal medicine are less explored.
- Prophylaxis in internal medicine is considered for chronic recurrent infections, persisting infections, exposure to microorganisms or vectors, bacteremia, and anatomical defects.
Purpose:
- To review the current landscape of prophylactic strategies in internal medicine.
- To identify situations where clear guidelines exist versus those requiring individualized approaches based on limited data.
Summary:
- Existing guidelines for conditions like malaria, tuberculosis, and rheumatic fever are often based on expert consensus rather than robust scientific data.
- Clinical studies inform prophylaxis for diseases such as chronic recurrent urinary tract infections.
- For conditions including Lyme disease, chronic bronchitis, cerebrospinal fluid leaks, and implants, there is a lack of guidance and sufficient clinical data, necessitating individualized patient management.
Impact:
- Highlights the need for more evidence-based guidelines in internal medicine prophylaxis.
- Emphasizes the importance of clinical judgment and cost-benefit analyses in managing infections when data is scarce.
- Informs clinical practice regarding the rational use of prophylactic measures in diverse internal medicine scenarios.